Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 19

1.

Classification and Personalized Prognosis in Myeloproliferative Neoplasms.

Grinfeld J, Nangalia J, Baxter EJ, Wedge DC, Angelopoulos N, Cantrill R, Godfrey AL, Papaemmanuil E, Gundem G, MacLean C, Cook J, O'Neil L, O'Meara S, Teague JW, Butler AP, Massie CE, Williams N, Nice FL, Andersen CL, Hasselbalch HC, Guglielmelli P, McMullin MF, Vannucchi AM, Harrison CN, Gerstung M, Green AR, Campbell PJ.

N Engl J Med. 2018 Oct 11;379(15):1416-1430. doi: 10.1056/NEJMoa1716614.

PMID:
30304655
2.

Non-thermal focused ultrasound induced reversible reduction of essential tremor in a rat model.

Sharabi S, Daniels D, Last D, Guez D, Zivli Z, Castel D, Levy Y, Volovick A, Grinfeld J, Rachmilevich I, Amar T, Mardor Y, Harnof S.

Brain Stimul. 2019 Jan - Feb;12(1):1-8. doi: 10.1016/j.brs.2018.08.014. Epub 2018 Aug 27.

PMID:
30181107
3.

Hydroxycarbamide Plus Aspirin Versus Aspirin Alone in Patients With Essential Thrombocythemia Age 40 to 59 Years Without High-Risk Features.

Godfrey AL, Campbell PJ, MacLean C, Buck G, Cook J, Temple J, Wilkins BS, Wheatley K, Nangalia J, Grinfeld J, McMullin MF, Forsyth C, Kiladjian JJ, Green AR, Harrison CN; United Kingdom Medical Research Council Primary Thrombocythemia-1 Study; United Kingdom National Cancer Research Institute Myeloproliferative Neoplasms Subgroup; French Intergroup of Myeloproliferative Neoplasms; and the Australasian Leukaemia and Lymphoma Group.

J Clin Oncol. 2018 Aug 28:JCO2018788414. doi: 10.1200/JCO.2018.78.8414. [Epub ahead of print]

4.

Focused Ultrasound-Induced Suppression of Auditory Evoked Potentials in Vivo.

Daniels D, Sharabi S, Last D, Guez D, Salomon S, Zivli Z, Castel D, Volovick A, Grinfeld J, Rachmilevich I, Amar T, Liraz-Zaltsman S, Sargsyan N, Mardor Y, Harnof S.

Ultrasound Med Biol. 2018 May;44(5):1022-1030. doi: 10.1016/j.ultrasmedbio.2018.01.010. Epub 2018 Feb 28.

PMID:
29501283
5.

MicroRNA-101 expression is associated with JAK2V617F activity and regulates JAK2/STAT5 signaling.

Pagano F, Comoglio F, Grinfeld J, Li J, Godfrey A, Baxter J, Silber Y, Green AR.

Leukemia. 2018 Aug;32(8):1826-1830. doi: 10.1038/s41375-018-0053-9. Epub 2018 Feb 27. No abstract available.

6.

Mutant calreticulin knockin mice develop thrombocytosis and myelofibrosis without a stem cell self-renewal advantage.

Li J, Prins D, Park HJ, Grinfeld J, Gonzalez-Arias C, Loughran S, Dovey OM, Klampfl T, Bennett C, Hamilton TL, Pask DC, Sneade R, Williams M, Aungier J, Ghevaert C, Vassiliou GS, Kent DG, Green AR.

Blood. 2018 Feb 8;131(6):649-661. doi: 10.1182/blood-2017-09-806356. Epub 2017 Dec 27.

7.

Molecular determinants of pathogenesis and clinical phenotype in myeloproliferative neoplasms.

Grinfeld J, Nangalia J, Green AR.

Haematologica. 2017 Jan;102(1):7-17. doi: 10.3324/haematol.2014.113845. Epub 2016 Dec 1. Review.

8.

After 10years of JAK2V617F: Disease biology and current management strategies in polycythaemia vera.

Grinfeld J, Godfrey AL.

Blood Rev. 2017 May;31(3):101-118. doi: 10.1016/j.blre.2016.11.001. Epub 2016 Nov 15. Review.

PMID:
27884555
9.

Pathogenesis of Myeloproliferative Disorders.

Nangalia J, Grinfeld J, Green AR.

Annu Rev Pathol. 2016 May 23;11:101-26. doi: 10.1146/annurev-pathol-012615-044454. Review.

PMID:
27193452
10.

DNMT3A mutations occur early or late in patients with myeloproliferative neoplasms and mutation order influences phenotype.

Nangalia J, Nice FL, Wedge DC, Godfrey AL, Grinfeld J, Thakker C, Massie CE, Baxter J, Sewell D, Silber Y, Campbell PJ, Green AR.

Haematologica. 2015 Nov;100(11):e438-42. doi: 10.3324/haematol.2015.129510. Epub 2015 Aug 6. No abstract available.

11.

Effect of mutation order on myeloproliferative neoplasms.

Ortmann CA, Kent DG, Nangalia J, Silber Y, Wedge DC, Grinfeld J, Baxter EJ, Massie CE, Papaemmanuil E, Menon S, Godfrey AL, Dimitropoulou D, Guglielmelli P, Bellosillo B, Besses C, Döhner K, Harrison CN, Vassiliou GS, Vannucchi A, Campbell PJ, Green AR.

N Engl J Med. 2015 Feb 12;372(7):601-612. doi: 10.1056/NEJMoa1412098.

12.

PTCH1 expression at diagnosis predicts imatinib failure in chronic myeloid leukaemia patients in chronic phase.

Alonso-Dominguez JM, Grinfeld J, Alikian M, Marin D, Reid A, Daghistani M, Hedgley C, O'Brien S, Clark RE, Apperley J, Foroni L, Gerrard G.

Am J Hematol. 2015 Jan;90(1):20-6. doi: 10.1002/ajh.23857. Epub 2014 Oct 18.

13.

Potential of magnetic resonance-guided focused ultrasound for intracranial hemorrhage: an in vivo feasibility study.

Harnof S, Zibly Z, Hananel A, Monteith S, Grinfeld J, Schiff G, Kulbatski I, Kassell N.

J Stroke Cerebrovasc Dis. 2014 Jul;23(6):1585-91. doi: 10.1016/j.jstrokecerebrovasdis.2013.12.044. Epub 2014 Apr 13.

PMID:
24725813
14.

A common novel splice variant of SLC22A1 (OCT1) is associated with impaired responses to imatinib in patients with chronic myeloid leukaemia.

Grinfeld J, Gerrard G, Alikian M, Alonso-Dominguez J, Ale S, Valgañon M, Nteliopoulos G, White D, Marin D, Hedgley C, O'Brien S, Clark R, Goldman JM, Milojkovic D, Apperley JF, Foroni L.

Br J Haematol. 2013 Dec;163(5):631-9. doi: 10.1111/bjh.12591. Epub 2013 Oct 10.

PMID:
24117365
15.

The peripheral blood features of acute myeloid leukemia with inv(16)(p13.1q22).

Sreedhara S, Grinfeld J, Bain BJ.

Am J Hematol. 2013 Nov;88(11):975. doi: 10.1002/ajh.23555. Epub 2013 Aug 30. No abstract available.

16.

Transcranial magnetic resonance-guided focused ultrasound surgery for trigeminal neuralgia: a cadaveric and laboratory feasibility study.

Monteith SJ, Medel R, Kassell NF, Wintermark M, Eames M, Snell J, Zadicario E, Grinfeld J, Sheehan JP, Elias WJ.

J Neurosurg. 2013 Feb;118(2):319-28. doi: 10.3171/2012.10.JNS12186. Epub 2012 Nov 16.

PMID:
23157185
17.

Impact of propagating and standing waves on cavitation appearance.

Kenis AM, Grinfeld J, Zadicario E, Vitek S.

Ultrasound Med Biol. 2012 Jan;38(1):99-108. doi: 10.1016/j.ultrasmedbio.2011.08.002. Epub 2011 Nov 21.

PMID:
22104538
18.

Association of FcγRIIa R131H polymorphism with idiopathic pulmonary fibrosis severity and progression.

Bournazos S, Grinfeld J, Alexander KM, Murchison JT, Wallace WA, McFarlane P, Hirani N, Simpson AJ, Dransfield I, Hart SP.

BMC Pulm Med. 2010 Oct 7;10:51. doi: 10.1186/1471-2466-10-51.

19.

Update and critical appraisal of sevelamer in the management of chronic renal failure.

Grinfeld J, Inaba A, Hutchison AJ.

Open Access J Urol. 2010 Sep 2;2:161-70. doi: 10.2147/OAJU.S7227. Review.

Supplemental Content

Loading ...
Support Center